Table 3.
Intratumoral gene expression by treatment
Prior treatment |
Posttreatment |
Change (post-prior) |
|||||
---|---|---|---|---|---|---|---|
Gene | n | Median (min–max) | n | Median (min–max) | n | Median (min–max) | Pa |
TS | 38 | 3.16 (0.53–9.57) | 39 | 3.64 (0.67–11.30) | 34 | 0.38 (−2.33–7.25) | 0.10 |
DPD | 32 | 0.58 (0.14–1.87) | 33 | 0.68 (0.16–2.71) | 26 | 0.12 (−0.61–1.04) | 0.097 |
EGFR/HER1 | 37 | 1.59 (0.51–87.84) | 37 | 1.73 (0.10–89.64) | 32 | 0.15 (−1.88–41.89) | 0.10 |
HER2 | 33 | 0.04 (0.01–0.49) | 34 | 0.06 (0.01–1.87) | 28 | 0.01 (−0.29–1.61) | 0.26 |
HER3 | 37 | 4.51 (1.25–43.61) | 40 | 6.18 (0.89–12.86) | 33 | 0.87 (−36.31–8.18) | 0.38 |
Based on the Wilcoxon signed rank test.